Learn more about our Global Affairs work.
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.
Learn how AdvaMed® member companies can support earthquake relief efforts in Venezuela through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.
Review Namibia’s current medical device and equipment needs and learn how interested companies can provide support for medical supply and equipment needs in Namibia.
China GMP and ISO 13485: A Side-by-Side Comparison
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
Watch AdvaMed’s® exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS & TEMPO Model. Attendees will gain critical insights into model performance…
Scott Whitaker, president and CEO ofAdvaMed®, the world’s largest trade association representing medtech innovators, released the following statement after Fridays’ Supreme Court ruling on tariffs. Today, he published a more fulsome readout on LinkedIn, available here.